Skip to main content
. 2015 Feb 21;15:79. doi: 10.1186/s12885-015-1082-7

Table 1.

Patient characteristics

N %
Age Median (months) 36
Range (months) 13-216
Gender Male 35 60
Female 23 40
Site of Metastasis Bone/Bone Marrow/Lymph node 48 83
Lymph node alone 3 5
Others 7 12
Primary Sites Retroperitoneal 12 21
Adrenal Gland 41 71
Thorax 5 8
MYCN Amplified 19 34
(available for 56 pt) Non amplified or MYCN gain 37 66
Induction CT ICE/CECAT 21 36
Topo NB 37 64
Primary Tumor Reduction before Surgery* <50% 4 8
>50%, <95% 34 68
>95% 12 24
Surgery Radical 45 78
Not Radical 13 22
Response before HDC** CR/VGPR 21 37
PD 11 20
PR 24 43
RT Yes 28 48
No 30 52

LEGEND: pt, patient; BX, biopsy; CR, complete remission; VGPR, very good partial remission; PD, progressive disease; PR, partial response. For “others” site of metastasis was considered Bone or/and Bone Marrow or/and Lymph node plus lung or/and liver metastatis.

*In 7 patients surgery was performed at diagnosis, one patient died for an acute bleeding after accidental removal of central vein catheter.

**Two patients were not considered for this analysis; one patient died for acute bleeding and the later one died for acute renal failure.